Position in ALDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$339,820
+$53,032 QoQ
Shares Held
159,540
-6.0% QoQ
Ownership
0.264%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 108 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ALDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. ALDX ranks #212 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in ALDX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $339,820 | 159,540 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $286,788 | 169,698 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $844,790 | 163,087 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $697,939 | 133,705 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $469,426 | 122,566 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,881,537 | 501,137 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $149,229 | 29,906 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,538,587 | 656,510 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $98,849 | 29,864 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $104,070 | 31,826 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $111,494 | 31,765 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $321,159 | 48,078 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,323,710 | 515,341 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,807,270 | 282,706 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,719,474 | 247,051 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,216,644 | 227,836 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $72,786 | 16,375 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $67,012 | 16,753 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $205,082 | 23,358 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $198,852 | 17,551 | Shares | Defined | 2021-08-17 | |
| 2020-09-30 | $4,629,308 | 624,738 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||